Opaleye Management Inc. has filed its 13F form on May 29, 2024 for Q1 2024 where it was disclosed a total value porftolio of $411 Million distributed in 52 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ocular Therapeutix, Inc with a value of $60.5M, Harrow Health, Inc. with a value of $51.9M, Tg Therapeutics, Inc. with a value of $34.7M, Keros Therapeutics, Inc. with a value of $24.3M, and Rhythm Pharmaceuticals, Inc. with a value of $22.3M.

Examining the 13F form we can see an increase of $3.93M in the current position value, from $407M to 411M.

Opaleye Management Inc. is based out at Boston, MA

Below you can find more details about Opaleye Management Inc. portfolio as well as his latest detailed transactions.

Portfolio value $411 Million
Healthcare: $411 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History


  • Portfolio
  • No. of Stocks 52
  • Current Value $411 Million
  • Prior Value $407 Million
  • Filing
  • Period Q1 2024
  • Filing Date May 29, 2024
  • Form Type 13F-HR/A
  • Activity in Q1 2024
  • New Purchases 1 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.


Stay updated on Opaleye Management Inc. with notifications on news.